Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
The health savings account provider finished its fiscal year with triple-digit profit growth, and it plans to bump up its spending rate.
*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
Motley Fool Returns
Market-beating stocks from our flagship service.
Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 2025-08-28 22:25:23.588142.
Discounted offers are only available to new members. Stock Advisor list price is $199 per year.
Calculated by Time-Weighted Return since 2002. Volatility profiles based on trailing-three-year calculations of the standard deviation of service investment returns.
HealthEquity (HQY +0.00%), a financial company focused on health savings accounts (HSAs), reported its fiscal 2019 fourth-quarter and full year results on Monday.
Investors got a sneak peek of the company's year-end results in February when management pre-announced its fiscal 2019 sales metrics. Those numbers suggested that management was going to have no problems delivering on its guidance. The actual results showed that the company was able to drive 25% growth on the top-line and a triple-digit gain on the bottom line.
| Metric | Q4 2019 | Q4 2018 | Change (YOY) |
|---|---|---|---|
| Revenue | $75.8 million | $60.4 million | 25% |
| GAAP Net income | $13.1 million | $5.9 million | 122% |
| GAAP Earnings per share | $0.21 | $0.09 | 133% |
GAAP = Generally Accepted Accounting Principles. Data source: HealthEquity.
Image source: Getty Image.
Here's an overview of the key numbers from the full fiscal year 2019:
Check out the latest earnings call transcript for
HealthEquity.
CEO Jon Kessler noted that the company's strong growth continues to show it's winning more than its fair share of new business:
"We continue to outpace the market and gain market share as we edged up to 4 million HSA Members and eclipsed $8 billion of custodial assets. We are well positioned to have another great year for fiscal 2020 helping our members to connect health and wealth as we broaden our proprietary platform and deepen our relationships with our Network and Employer Partners."
On the conference call with investors, HealthEquity's founder and Vice Chair Dr. Steven Neeleman stated the company plans to ramp up it's spending to ensure that its platform remains built for long-term growth:
"Over the next several years, we will be investing in our proprietary code base and the security of our platform. The goals of these investments are to achieve continuous to plan and capability, which increases speed to market and enterprise class security. This is not only prudent planning for continued fast growth. It's also a power move versus subscale competitors who will not or perhaps cannot deploy technology capital effectively. Their return on these investments is long term, sustainable and profitable growth."
Management expects that fiscal 2020 will be another year of strong top-line growth for the business. However, the company's decision to ramp up spending on its platform is expected to take its toll on net income growth. In response, here's a look at the guidance that is being shared for full-year fiscal 2020:
For context, Wall Street was expecting the company to guide for $336.6 million in revenue and $1.31 in adjusted earnings per share for the fiscal year, so this forecast is a bit worse than market-watchers were hoping for.
The good news for investors is that HealthEquity's management team tends to share conservative guidance up front, and then beat its own targets. For example, management initially predicted that fiscal 2019 sales would land between $276 million and $282 million while adjusted EPS would land between $0.98 and $1.04. Both of these targets were raised consistently throughout the year and the actual numbers came in at $287.2 million and $1.19, respectively. In other words, investors can probably view its initial targets for fiscal 2020 as the floor, not the ceiling.
The most important takeaway from this earnings report is that HealthEquity is performing well on nearly every metric that matters. The company continues to gain share in the growing HSA market. New members and a growing asset base are fueling strong top-line growth. The sales gains are allowing margins to rise across the board and are translating into outsized growth on the bottom line. Finally, management is making investments in the business that should allow it to continue to grab market share and open up new opportunities down the road.
Overall, this report suggests that the bull case for HealthEquity remains firmly on track. With plenty of room left for future expansion, this is a great stock for growth-focused investors to get to know.